Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Most Read

  1. US doctors propose universal health care to fix ‘dysfunctional’ system
  2. US Health Secretary proposes changes to Medicare plans
  3. Trump’s drug price plans: a ‘sugar-coated nothing pill’?
  4. Biotech M&A: will the 2018 surge last?
  5. AbbVie’s risankizumab edges closer to approval for moderate-to-severe psoriasis

Company A-Z

Latest Content

Trump’s drug price plans: a ‘sugar-coated nothing pill’?

In a long-awaited speech delivered at the White House Rose Garden on Friday, Trump launched what he described as ‘the most sweeping action in history to lower the price of prescription drugs for the American people’. However, with big pharma left relatively unscathed, will the proposals have any real impact on drug pricing?

Biotech M&A: will the 2018 surge last?

Analysts are predicting a surge of M&A activity in the biotech space, with large pharma firms looking to pad their pipelines with new acquisitions, US tax reform freeing up cash flow, and rapidly-consolidating US healthcare buyers likely to put more pressure on the price of existing drugs. How is the biotech M&A landscape likely to develop over the course of 2018?

FDA seeks to shut down unauthorised stem cell clinics

The US Food and Drugs Administration (FDA) is seeking permanent injunctions to stop two stem cell clinics in California and Florida from marketing stem cell products without FDA approval after reports of patients being made blind.

The CAPA Hierarchy

Executive director of pharma biotech at NSF International Jim Morris introducing a concept called the CAPA Hierarchy.

Read our magazine

Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.

Send me notifications of new editions:

Go Top